CPH.TO vs. REVG

Last updated Jun 9, 2026

CPH.TO (Cipher Pharmaceuticals Inc.) and REVG (REV Group, Inc.) are both stocks. CPH.TO operates in Drug Manufacturers - Specialty & Generic (Healthcare), while REVG operates in Farm & Heavy Construction Machinery (Industrials). Over the past 5 years, CPH.TO returned 61.01%/yr vs 36.55%/yr for REVG. At a 0.08 correlation, their price movements are largely independent.

Performance

CPH.TO vs. REVG - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Cipher Pharmaceuticals Inc. (CPH.TO) and REV Group, Inc. (REVG). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CPH.TO is traded in CAD, while REVG is traded in USD. To make them comparable, the REVG values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, CPH.TO achieves a 12.08% return, which is significantly higher than REVG's 6.70% return.

CPH.TO

• 1D: 0.24%
• 1M: -14.49%
• YTD: 12.08%
• 6M: 15.14%
• 1Y: 27.40%
• 3Y*: 64.67%
• 5Y*: 61.01%
• 10Y*: 8.89%

REVG

• 1D: 0.09%
• 1M: 1.80%
• YTD: 6.70%
• 6M: 15.26%
• 1Y: 45.55%
• 3Y*: 91.92%
• 5Y*: 36.55%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CPH.TO vs. REVG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CPH.TO Cipher Pharmaceuticals Inc.	12.08%	5.17%	158.48%	44.27%	116.95%	90.32%	-38.00%	-12.28%	-65.10%	7.93%
REVG REV Group, Inc.	6.70%	83.03%	126.62%	42.53%	-3.60%	62.07%	-28.57%	58.89%	-74.67%	21.93%

Correlation

The correlation between CPH.TO and REVG is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (All Time) Calculated using the full available price history since Jan 27, 2017	0.08

Fundamentals

Market Cap CPH.TO : CA$435.58M REVG : $3.15B
EPS CPH.TO : CA$1.19 REVG : $1.93
PE Ratio CPH.TO : 14.22 REVG : 33.05
PEG Ratio CPH.TO : 0.17 REVG : 0.22
PS Ratio CPH.TO : 8.65 REVG : 1.28
PB Ratio CPH.TO : 3.28 REVG : 7.57
Total Revenue (TTM) CPH.TO : CA$50.92M REVG : $2.46B
Gross Profit (TTM) CPH.TO : CA$37.95M REVG : $369.80M
EBITDA (TTM) CPH.TO : CA$25.12M REVG : $168.60M

Return for Risk

CPH.TO vs. REVG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CPH.TO

CPH.TO Risk / Return Rank: 64
CPH.TO Sharpe Ratio Rank: 64
CPH.TO Sortino Ratio Rank: 65
CPH.TO Omega Ratio Rank: 61
CPH.TO Calmar Ratio Rank: 66
CPH.TO Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CPH.TO vs. REVG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cipher Pharmaceuticals Inc. (CPH.TO) and REV Group, Inc. (REVG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CPH.TO	REVG	Difference
Sharpe ratio: Return per unit of total volatility	0.66	1.79	-1.13
Sortino ratio: Return per unit of downside risk	1.41	2.60	-1.19
Omega ratio: Gain probability vs. loss probability	1.16	1.38	-0.21
Calmar ratio: Return relative to maximum drawdown	1.21	2.41	-1.21
Martin ratio: Return relative to average drawdown	2.53	6.40	-3.87
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CPH.TO vs. REVG - Sharpe Ratio Comparison

The current CPH.TO Sharpe Ratio is 0.66, which is lower than the REVG Sharpe Ratio of 1.79. The chart below compares the historical Sharpe Ratios of CPH.TO and REVG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CPH.TO	REVG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.66	1.79	-1.13
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	1.23	0.84	+0.39
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.15	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.08	0.28	-0.19

Drawdowns

CPH.TO vs. REVG - Drawdown Comparison

The maximum CPH.TO drawdown since its inception was -97.90%, which is greater than REVG's maximum drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for CPH.TO and REVG.

Drawdown Indicators

	CPH.TO	REVG	Difference
Max Drawdown Largest peak-to-trough decline	-97.90%	-86.65%	-11.25%
Max Drawdown (1Y) Largest decline over 1 year	-22.83%	-22.48%	-0.35%
Max Drawdown (3Y) Largest decline over 3 years	-42.50%	-22.48%	-20.02%
Max Drawdown (5Y) Largest decline over 5 years	-42.50%	-42.90%	+0.40%
Max Drawdown (10Y) Largest decline over 10 years	-94.63%	—	—
Current Drawdown Current decline from peak	-14.49%	-6.90%	-7.59%
Average Drawdown Average peak-to-trough decline	-64.03%	-39.81%	-24.22%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.84%	8.32%	+2.52%

Volatility

CPH.TO vs. REVG - Volatility Comparison

Cipher Pharmaceuticals Inc. (CPH.TO) has a higher volatility of 13.91% compared to REV Group, Inc. (REVG) at 0.80%. This indicates that CPH.TO's price experiences larger fluctuations and is considered to be riskier than REVG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CPH.TO	REVG	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.91%	0.80%	+13.11%
Volatility (6M) Calculated over the trailing 6-month period	28.45%	14.46%	+13.99%
Volatility (1Y) Calculated over the trailing 1-year period	41.97%	30.32%	+11.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	49.95%	44.15%	+5.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	60.78%	51.79%	+8.99%

Dividends

CPH.TO vs. REVG - Dividend Comparison

Neither CPH.TO nor REVG has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
CPH.TO Cipher Pharmaceuticals Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
REVG REV Group, Inc.	0.28%	0.39%	10.07%	1.10%	1.58%	1.06%	1.14%	1.64%	2.66%	0.46%

Financials

CPH.TO vs. REVG - Profitability Comparison

The chart below illustrates the profitability comparison between Cipher Pharmaceuticals Inc. and REV Group, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CPH.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported a gross profit of 8.35M and revenue of 12.30M. Therefore, the gross margin over that period was 67.9%.

REVG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, REV Group, Inc. reported a gross profit of 102.60M and revenue of 664.40M. Therefore, the gross margin over that period was 15.4%.

CPH.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported an operating income of 5.50M and revenue of 12.30M, resulting in an operating margin of 44.7%.

REVG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, REV Group, Inc. reported an operating income of 57.60M and revenue of 664.40M, resulting in an operating margin of 8.7%.

CPH.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported a net income of 6.06M and revenue of 12.30M, resulting in a net margin of 49.3%.

REVG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, REV Group, Inc. reported a net income of 28.90M and revenue of 664.40M, resulting in a net margin of 4.4%.

Frequently Asked Questions

Can I hold both CPH.TO and REVG in my portfolio?

CPH.TO and REVG have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.